Press Releases | Adaptive Biotechnologies

Skip to main navigation

Overview(current)

Stock
Stock Quote & Chart
Analyst Coverage

Governance
Leadership
Board of Directors
Committee Composition
Governance Documents

SEC Filings(current)

News & Events
Press Releases
Events
Presentations

Resources
Frequently Asked Questions
Email Alerts
Investor Contact

Press Releases

Looking for media resources?
Please visit our media resource center.

Year

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions

12-07-2024 at 6:31 PM EST
Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting

12-03-2024 at 7:30 AM EST
Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results

11-07-2024 at 4:05 PM EST
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma

11-07-2024 at 7:31 AM EST
Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024

10-09-2024 at 4:05 PM EDT
Adaptive Announces IVDR Certification for clonoSEQ® in European Union

08-29-2024 at 7:30 AM EDT
Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

08-22-2024 at 4:03 PM EDT
Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results

08-01-2024 at 4:05 PM EDT
Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024

07-11-2024 at 4:05 PM EDT
Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

05-31-2024 at 7:30 AM EDT

Displaying 1 - 10 of 164

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Print Page
RSS Feeds
Contacts

email

Keep up to date with Adaptive

Sign up to receive our press releases via email

© Adaptive Biotechnologies. All Rights Reserved. Legal & Privacy

Privacy Policy | Cookie Policy | Notice at Collection | Do Not Sell or Share My Info (CA Residents) | Terms of Service | Code of Conduct

© Adaptive Biotechnologies. All Rights Reserved. Legal & Privacy